Vitamin K + anticoagulants
Vitamin K counteracts warfarin and similar medications. Even small supplement doses can disrupt anticoagulation therapy. Learn which supplements contain hidden K1 or K2 and how to manage the risk.
Vitamin K is required for synthesis of clotting factors; warfarin and similar anticoagulants work by antagonizing vitamin K recycling—so sudden large changes in vitamin K intake from supplements or diet can destabilize INR. This is primarily a medication management issue: patients should follow prescriber guidance and not add hidden K1/K2 from multivitamins or “bone” stacks without review. The safety framing for supplement users is consistency and transparency, not scare-mongering about leafy greens alone.
| Topic | Why it matters | Supplement angle | Action |
|---|---|---|---|
| Warfarin therapy | INR sensitive to vitamin K changes | Hidden K in MVM | Clinician coordination |
| K1 vs K2 marketing | Both are vitamin K activity | Label claims vary | Do not assume “safe K2” |
| Fish oil + anticoagulants | Bleeding risk additive | Separate issue from K | Medical review |
| New supplement | Any vitamin K dose | Even small amounts | Tell your care team |
Source: NIH ODS (vitamin K); medication interaction references should be confirmed with prescribing clinicians.
Never stealth-change vitamin K. Starting or stopping a K-containing multivitamin can move INR as much as “big” diet changes for some patients.
Read labels for phytonadione and menaquinone. Those names mean vitamin K1 and K2 forms.
Do not use this page to adjust warfarin. This is educational; dosing changes belong to your clinician and INR monitoring.
Multivitamins, bone formulas, and some “longevity” stacks include K2; combined products with vitamin D and calcium are common.
NutriAudit helps users export a clear list of vitamin-K-containing products to discuss with a pharmacist or prescriber.
Warfarin interacts with vitamin K intake variability more than with a single static low dose. Sudden large swings from kale powders, green drinks, or new vitamin K supplements matter more than many patients realize.
Direct oral anticoagulants follow different interaction rules than warfarin, but “natural” K2 products are not automatically safe in every regimen—always confirm with the prescribing team.
Bone formulas, “artery support” blends, and some multis add K1 or K2. Even if the dose looks small, combining multiple products can change weekly vitamin K exposure enough to disturb INR stability on warfarin.
Never change anticoagulant-related supplements without a plan for monitoring; keep a written list of start/stop dates for cardiology or anticoagulation clinics.
Clinicians often recommend consistent vitamin K intake rather than elimination; sudden changes—whether from diet or supplements—are the bigger problem.
Do not assume safety based on marketing; any meaningful vitamin K exposure should be reviewed with your anticoagulation clinician.
High-dose vitamin E and fish oil can affect bleeding risk through different mechanisms—still disclose all supplements.
Small inconsistent doses can still matter for anticoagulation stability; disclose every product and let your clinician interpret risk.
Use NutriAudit to audit your full stack for hidden overlaps.
Audit your supplement stackDisclaimer: NutriAudit is a decision-support tool designed to help you review your supplement stack for potential duplicate, conflicting, or excessive ingredients. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making changes to your supplement routine, especially if you are pregnant, nursing, taking medications, or have a medical condition.
Based on reference standards from FDA, EFSA, TGA, and MHLW.
Last updated: 2026-04-07 · Data sourced from FDA Dietary Reference Intakes, EFSA Scientific Opinions, and NIH Office of Dietary Supplements where applicable.